According to KFF analysis of Centers for Medicare & Medicaid Services 2018-2022 Medicare Part D spending by drug increased from $57 Million to $5.7 Billion.[2] The June 13, 2024 article in Fierce Healthcare[3] on GLP-1 drugs noted that Blue Cross Blue Shield of Michigan will no longer cover these drugs starting in January 2025, and will be changing the prior authorization criteria starting in August 2024, for those members that are in large group fully insured commercial plans
Expression of glucagon-like peptide 1 receptor in a murine C cell line: Regulation of calcitonin gene by glucagon-like peptide 1
No hidden fees, no additional charges for supplies or shipping
Call (620) 617-0222 or visit us at 1005 Williams St, Great Bend, KS to schedule your consultation
There are several B12 supplements available, and some (like B12 tablets) have high dosages far above the daily recommended value
Were here to support your journey in a way that works for you
